NIH Awards Lucigen $2.8M SBIR Grant for POC Influenza Test | GenomeWeb

NEW YORK (GenomeWeb News) – Lucigen today said it has been awarded a $2.8 million Small Business Innovation Research grant from the National Institutes of Health to develop a point-of-care diagnostic test for influenza.

The grant, the largest SBIR award ever received by the Middleton, Wis.-based company, will go toward the development of a molecular test for influenza A and B and respiratory syncytial virus. It will be able to test multiple RNA pathogens, Lucigen said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.